文献速递中医骨伤中药与中成药合理使用针灸推拿

骨质疏松治疗:现有药物与未来进展

Osteoporosis treatment: current drugs and future developments.
PubMed 文献 · Front Pharmacol · 2024-08-12

本文综述了临床应用及研发中的抗骨质疏松药物,指出常用药物多通过抑制骨吸收、促进骨形成或双重作用起效,但多存在靶点单一、毒副作用大的缺点。中药来源广、多在免疫与骨质疏松关系调节上有独特优势,针灸联合药物疗效显著,但中药靶细胞与分子机制尚未完全阐明,疾病病理机制认识不足。

要点

  • 抗骨质疏松药多靶点单一、毒副作用大,需关注联合与个体化用药。
  • 中药在调节骨质疏松与免疫系统关系方面有独特优势。
  • 针灸联合药物治疗骨质疏松有显著疗效。

核心结论

  • 抗骨质疏松药物多存在靶点单一和毒副作用大的缺点。
  • 中药在调节骨质疏松与免疫系统关系上有独特优势,针灸联合药物疗效显著。
  • 中药防治骨质疏松的靶细胞与分子机制尚未完全阐明。

研究设计与样本

  • 本文为综述,回顾临床应用及研发中的抗骨质疏松药物。

主要发现

  • 抗骨质疏松药物通常通过抑制骨吸收、促进骨形成或双重作用起效。
  • 中药种类多、来源广且多为植物,在免疫与骨质疏松关系调节上有优势。
  • 针灸联合药物治疗骨质疏松疗效显著。

临床怎么用

  • 临床可关注中药在免疫调节与骨质疏松关系中的潜在应用。
  • 可考虑针灸联合药物治疗骨质疏松以提升疗效。

局限性

  • 中药防治骨质疏松的靶细胞与特定分子机制尚未完全阐明。
  • 目前对骨质疏松病理机制缺乏全面认识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Osteoporosis is a common systemic metabolic disease characterized by a decrease in bone density and bone mass, destruction of bone tissue microstructure, and increased bone fragility leading to fracture susceptibility. Pharmacological treatment of osteoporosis is the focus of current research, and anti-osteoporosis drugs usually play a role in inhibiting bone resorption, promoting bone formation, and having a dual role. However, most of the drugs have the disadvantages of single target and high toxic and side effects. There are many types of traditional Chinese medicines (TCM), from a wide range of sources and mostly plants. Herbal plants have unique advantages in regulating the relationship between osteoporosis and the immune system, acupuncture therapy has significant therapeutic effects in combination with medicine for osteoporosis. The target cells and specific molecular mechanisms of TCM in preventing and treating osteoporosis have not been fully elucidated. At present, there is a lack of comprehensive understanding of the pathological mechanism of the disease. Therefore, a better understanding of the pathological signaling pathways and key molecules involved in the pathogenesis of osteoporosis is crucial for the design of therapeutic targets and drug development. In this paper, we review the development and current status of anti-osteoporosis drugs currently in clinical application and under development to provide relevant basis and reference for drug prevention and treatment of osteoporosis, with the aim of promoting pharmacological research and new drug development.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Chen YJ, Jia LH, Han TH, et al. Osteoporosis treatment: current drugs and future developments. Front Pharmacol. 2024. PMID: 39188952. doi:10.3389/fphar.2024.1456796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。